Registered entities
Bioatla, Inc.
Reg. No. 1826892United States
Bioatla Llc
Reg. No. 208760096United States
Innovation
48 patent families (35 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 10,909 times.
| Year | Filings |
|---|---|
| 2015 | 11 |
| 2016 | 13 |
| 2017 | 19 |
| 2018 | 21 |
| 2019 | 23 |
| 2020 | 24 |
| 2021 | 27 |
| 2022 | 26 |
| 2023 | 27 |
| 2024 | 28 |
| 2025 | 26 |
| 2026 | 14 |
Social engagement
Social engagement: 6.5K social following, 2 posts in the last 12 months — around the industry typical range.
Investor mix
17 investors on record; lead investors include Soleus Capital, HBM Healthcare Investments; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 71% |
| Private equity | 3 | 18% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 1 | 6% |
Recent activity
8 Sep 2025
Product launch
Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC)
3 Jul 2025
Recognition